GONAL-f 900 IU/1.44 mL solution for injection in pre-filled pen
Sponsors
Santiago Dexeus Font Fundacio Privada, Martin-Luther-Universitaet Halle-Wittenberg
Conditions
Male Infertilityinfertility
Phase 4
PErsonalized Addition of Recombinant LH in suboptimal responders >35 years old (POSEIDON group 2). A randomized controlled trial
Not yet recruitingCTIS2024-514035-19-00
Target: 120Updated: 2024-09-23
A Multicenter Randomized Controlled Trial Assessing the Efficacy and Safety of Recombinant Human Follicle Stimulating Hormone (r-hFSH-alfa originator) and Human Chorionic Gonadotropin (hCG) in Enhancing Sperm Concentration in Men with Oligozoospermia, Low Testosterone, and Normal FSH Serum Levels (APHRODITE Group 3): A Collaborative Research Initiative
Not yet recruitingCTIS2025-525005-20-00
Target: 99Updated: 2026-05-19